Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
IQ’s link to brain structure, function in children may be a mirage
A child’s socioeconomic status, screen time and amount of sleep all show stronger associations with measures of brain structure and function, according to an imaging study of nearly 12,000 9- to 10-year-olds.
IQ’s link to brain structure, function in children may be a mirage
A child’s socioeconomic status, screen time and amount of sleep all show stronger associations with measures of brain structure and function, according to an imaging study of nearly 12,000 9- to 10-year-olds.
By
Natalia Mesa
11 June 2026 | 5 min read
When autistic kids grow up, Chapter 2: “You need to go to college”
With just a high school equivalency degree and struggling as a single mother, Tempest McDonald is forced to shift her priorities.
When autistic kids grow up, Chapter 2: “You need to go to college”
With just a high school equivalency degree and struggling as a single mother, Tempest McDonald is forced to shift her priorities.
By
Brady Huggett
11 June 2026 | 28 min listen
Noncoding RNA sways core autism traits in mice
Small deletions in an X-linked RNA alter social and repetitive behaviors in male mice without broadly affecting learning or memory.
Noncoding RNA sways core autism traits in mice
Small deletions in an X-linked RNA alter social and repetitive behaviors in male mice without broadly affecting learning or memory.
By
Giorgia Guglielmi
11 June 2026 | 4 min read